Can J Psychiatry

1. UELAND T, Oie MG, Vaskinn A
   Methodological Concerns Regarding a Meta-Analysis of the Subjective Scale to Investigate Cognition in Schizophrenia (SSTICS).
   Can J Psychiatry. 2026 May 7:7067437261448737. doi: 10.1177/07067437261448737.
   

   >> Share

   
   

   
   PLoS One

2. GIL JY, Min KH, Kim JH, Park JH, et al
   Risk of Parkinson's disease in patients with schizophrenia: Impact of antipsychotic medication use.
   PLoS One. 2026;21:e0346233.
   

   >> Share

   
   

   
   Psychiatry Res

3. RAMOS MA, Hernandez C, Arranz B
   Iron dysregulation across the schizophrenia lifespan: A systematic review from prenatal risk to postmortem findings.
   Psychiatry Res. 2026;362:117193.
   

   >> Share

   
   
4. CHEN W, Xu C, Deng W, Liang J, et al
   Impact of second-generation antipsychotics on white matter microstructure in schizophrenia: A DTI study.
   Psychiatry Res. 2026;362:117182.
   

   >> Share

   
   
5. KOC I, Koc EA
   The effects of physical exercise on simple inflammatory markers, systemic immune inflammation index, and systemic immune response index in patients with schizophrenia.
   Psychiatry Res. 2026;362:117187.
   

   >> Share

   
   

   
   Psychol Med

6. EDELHOFF H, van Os J, van Amelsvoort T, Simons CJP, et al
   Clusters of social and substance use-related risks are associated with the duration of untreated psychosis.
   Psychol Med. 2026;56:e126.
   

   >> Share

   
   
7. ROMER THOMSEN K, Thylstrup B, Hesse M, Lindholst C, et al
   Changes in cannabis potency and cannabis-related psychiatric harms: a 23-year ecological study in Denmark.
   Psychol Med. 2026;56:e124.
   

   >> Share

   
   

   
   Schizophr Res

8. LAN M, Wang L, Wang B, Cao T, et al
   Dynamic and integrative visual processing abilities in schizophrenia.
   Schizophr Res. 2026;294:155-163.
   

   >> Share

   
   
9. RYU S, Kim JW, Jhon M, Chung YC, et al
   Perplexity and pseudo-perplexity as objective measures of linguistic deficits in schizophrenia: Evidence from a Korean-Speaking cohort.
   Schizophr Res. 2026;294:147-154.
   

   >> Share

   
   
10. WIJNRUIT J, Voorhout K, Lumsden V, Verheijde-Zeyl C, et al
    Corrigendum to "Twenty-two year outcome of a first psychotic episode in Suriname." [Schizophrenia Research, vol. 294, 2026, pages 73-75. SCHRES10980].
    Schizophr Res. 2026 May 5:S0920-9964(26)00142.
    

    >> Share

    
    
11. EDWARDS CJ, Pillny M, Beck K, Cella M, et al
    A scoping review of targeted psychological interventions for negative symptoms in schizophrenia.
    Schizophr Res. 2026;294:140-146.
    

    >> Share

    
    
12. YANG Q, Wu HQ, Zhu ZH, Yin XY, et al
    Association of plasma DISC1 levels with expression of negative symptoms of first-episode schizophrenia.
    Schizophr Res. 2026;294:133-139.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share